NERV 주식 스냅샷
가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$4.95
시가총액
$217M
P/E (TTM)
-0.1
EPS (TTM)
$-34.67
매출 (TTM)
$0
배당 수익률
—
ROE
339.5%
부채/자본
—
52주 범위
$2 – $12
NERV 주가 차트
기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
이동 평균 및 오버레이
거래량
오실레이터
모멘텀 및 추세
Configure
10년 성과
매출, 순이익, 마진 및 EPS 추세
매출 및 순이익$0
2017-12-31→2024-12-31
EPS$-34.67
2019-12-31→2025-12-31
잉여현금흐름—
2017-12-31→2017-12-31
마진—
가치 평가
P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
NERV
동종업계 중앙값
P/E (TTM)
-0.1
—
P/B
-1.5
1.4
수익성
총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
NERV
동종업계 중앙값
ROA
-434.3%
-58.9%
ROE
339.5%
-83.3%
재무 건전성
부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
NERV
동종업계 중앙값
Current Ratio (유동비율)
36.3
8.5
Quick Ratio (당좌 비율)
35.9
—
성장
매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
NERV
동종업계 중앙값
주당 지표
EPS, 주당 순자산, 주당 현금 흐름, 주당 배당금
지표
5년 추세
NERV
동종업계 중앙값
EPS (Diluted) (EPS (희석))
$-34.67
—
자본 효율성
자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
NERV
동종업계 중앙값
NERV 분석가 합의
강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수9 명의 애널리스트
적극 매수
222.2%
매수
444.4%
보유
333.3%
매도
00.0%
적극 매도
00.0%
12개월 목표 주가
3 명의 애널리스트
· 2026-08-19
중앙값$10.00
← 모든 목표가 하회
$4.95
저가$7.00
고가$14.00
중앙값 목표$10.00
+102.2%
평균 목표$10.33
+109.0%
실적 기록
EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.19%
기간
EPS Actual
EPS 예상
서프라이즈
2026년 6월 30일
$-0.17
$-0.12
-0.05%
2026년 3월 31일
$-0.17
$-0.13
-0.04%
2025년 12월 31일
$-0.64
$-0.31
-0.33%
2025년 6월 30일
$-0.43
$-0.92
0.49%
2025년 3월 31일
$-0.50
$-1.09
0.59%
2024년 12월 31일
$-0.56
$-1.07
0.51%
동종 기업 비교(GICS 하위 산업)
주요 지표 대 섹터 동종 기업
티커
시가총액
P/E
매출 YoY
순이익률
ROE
매출 총이익률
NERV
$174M
-0.1
—
—
339.5%
—
ORGO
$658M
34.5
17.0%
6.6%
13.9%
—
AKBA
$427M
-80.5
47.5%
-2.3%
-17.3%
—
DTIL
$100M
-1.2
-50.1%
-133.4%
-72.4%
—
TARA
$286M
-4.0
—
—
-33.7%
—
RNA
$10.91B
-14.5
72.1%
-3650.4%
-47.5%
—
CNXU
—
—
—
—
—
—
IMUX
—
-0.9
—
—
—
—
TNXP
$200M
-1.1
29.8%
-946.2%
-60.0%
—
NBP
—
—
—
—
—
—
ABOS
$128M
-1.1
—
—
-129.4%
—
전체 기본 지표
연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서14
NERV의 연간 손익계산서 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
·
$0
$0
$0
·
$41M
$0
$0
$0
R&D Expense
$6M
$12M
$13M
$15M
$32M
$22M
$58M
$35M
$30M
SG&A Expense
$9M
$10M
$10M
$11M
$13M
$17M
$18M
$17M
$11M
Operating Expenses
$15M
$22M
$23M
$25M
$45M
$39M
$76M
$52M
$41M
Operating Income
$-15M
$-22M
$-23M
$-25M
$-45M
$2M
$-76M
$-52M
$-41M
Interest Income
$948.1K
$1M
$1M
$556.9K
$16.5K
$161.2K
$1M
$2M
$941.8K
Pretax Income
·
·
·
$-32M
$-52M
$2M
$-74M
$-50M
$-41M
Income Tax
·
·
·
·
$-2M
·
$-2M
$0
$-9M
Net Income
$-293M
$1M
$-30M
$-32M
$-50M
$2M
$-72M
$-50M
$-32M
EPS (Basic)
$-34.67
$0.19
$-4.61
$-6.01
$-9.35
$0.05
$-1.85
·
·
EPS (Diluted)
$-34.67
$0.19
$-4.61
$-6.01
$-9.35
$0.05
$-1.85
·
·
Shares (Basic)
8,463,581
7,568,981
6,506,372
5,340,194
5,340,196
40,823,717
39,014,302
·
·
Shares (Diluted)
8,463,581
7,573,763
6,506,372
5,340,194
5,340,196
40,916,871
39,014,302
·
·
EBITDA
$-15M
·
·
·
$-45M
$2M
$-76M
$-52M
$-41M
대차대조표22
NERV의 연간 대차대조표 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
Cash & Equivalents
$82M
$21M
$41M
$36M
$61M
$25M
$21M
$50M
$26M
Short-term Investments
·
·
·
·
·
·
$24M
$38M
$102M
Prepaid Expense
$697.7K
$806.9K
$989.9K
$848.1K
$1M
$2M
$1M
$2M
$1M
Current Assets
$83M
$22M
$42M
$40M
$62M
$27M
$47M
$90M
$130M
PP&E (Net)
$0
$5.4K
$10.9K
$16.3K
·
·
$16.0K
$33.5K
$50.9K
Goodwill
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
Intangibles
·
·
·
·
·
$15M
$15M
$34M
$34M
Other Non-current Assets
·
·
·
·
·
$14.8K
$14.8K
$14.8K
$14.8K
Total Assets
$98M
$37M
$57M
$55M
$77M
$58M
$77M
$139M
$184M
Accounts Payable
$639.7K
$2M
$2M
$969.7K
$2M
$995.6K
$2M
$2M
$1M
Short-term Debt
·
·
·
·
·
·
·
·
$4M
Current Liabilities
$2M
$3M
$3M
$1M
$3M
$3M
$7M
$4M
$7M
Capital Leases
·
·
·
·
·
·
$111.2K
·
·
Deferred Tax
·
·
·
·
·
$2M
$2M
$4M
$4M
Other Non-current Liabilities
·
·
·
·
·
·
·
$29.0K
$29.9K
Total Liabilities
$234M
$63M
$85M
$75M
$69M
$5M
$50M
$49M
$52M
Total Debt
·
·
·
·
·
·
·
·
$4M
Common Stock
$4.3K
$699
$699
$534
$534
$4.3K
$3.9K
$3.9K
$3.9K
Retained Earnings
$-689M
$-395M
$-397M
$-367M
$-335M
$-285M
$-287M
$-215M
$-164M
Stockholders' Equity
$-141M
$-26M
$-28M
$-20M
$8M
$53M
$28M
$90M
$132M
Liabilities + Equity
$98M
$37M
$57M
$55M
$77M
$58M
$77M
$139M
$184M
Shares Outstanding
43,274,398
6,993,406
6,993,406
5,340,193
5,340,196
5,340,196
39,084,121
38,937,971
38,749,343
현금 흐름12
NERV의 연간 현금 흐름 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
D&A
$5.4K
$5.4K
$5.4K
·
·
$16.0K
$17.5K
$17.5K
$11.1K
Stock-based Comp
$1M
$1M
$2M
$4M
$5M
$10M
$9M
$8M
$5M
Other Non-cash
·
·
·
·
·
$-45M
$20M
$29.4K
$30M
Operating Cash Flow
$-14M
$-20M
$-15M
$-25M
$-25M
$-34M
$-43M
$-42M
$3M
CapEx
·
·
·
$16.3K
·
·
·
·
$52.4K
Investing Cash Flow
$0
$0
$0
$-16.3K
·
$25M
$14M
$69M
$-107M
Stock Repurchased
·
·
·
·
·
·
·
·
$389
Net Stock Activity
·
·
·
·
·
·
·
·
$-389
Financing Cash Flow
$74M
·
$20M
$-5
$60M
$13M
$525.0K
$-3M
$47M
Net Change in Cash
$61M
$-20M
$5M
$-25M
$35M
$4M
$-29M
$24M
$-57M
Taxes Paid
$0
$0
·
·
·
·
·
·
·
Free Cash Flow
·
·
·
·
·
·
·
·
$3M
수익성7
NERV의 연간 수익성 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
Operating Margin
·
·
·
·
·
4.5%
·
·
·
Net Margin
·
·
·
·
·
4.7%
·
·
·
Pretax Margin
·
·
·
·
·
4.7%
·
·
·
EBITDA Margin
·
·
·
·
·
4.5%
·
·
·
ROA
-434.3%
·
·
·
-74.1%
2.9%
-66.6%
-31.1%
-19.9%
ROE
339.5%
·
·
·
-276.8%
3.5%
-173.3%
-52.3%
-24.1%
ROIC
·
·
·
·
-549.0%
·
-264.8%
-57.3%
-23.4%
유동성 및 지급능력3
NERV의 연간 유동성 및 지급능력 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
Current Ratio
36.3
·
·
·
22.1
8.7
7.1
24.9
18.9
Quick Ratio
35.9
·
·
·
21.6
8.0
6.9
24.4
18.7
Debt / Equity
·
·
·
·
·
·
·
·
0.0
효율성1
NERV의 연간 효율성 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
Asset Turnover
·
·
·
·
·
0.6
0.0
0.0
0.0
주당5
NERV의 연간 주당 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
Book Value / Share
$-3.25
·
·
·
$0.19
$1.23
$0.71
$2.32
$3.40
Revenue / Share
·
·
·
·
·
$1.01
·
·
·
Cash Flow / Share
$-1.60
·
·
·
$-0.58
$-0.83
·
·
·
Cash / Share
$1.90
·
·
·
$1.42
$0.59
$0.55
$1.29
$0.67
EPS (TTM)
$-34.67
$0.19
$-4.61
$-6.01
$-9.35
$0.05
$-1.85
·
·
가치 평가 (TTM)13
NERV의 연간 가치 평가 (TTM) 데이터
지표
추세
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue TTM
·
$0
$0
$0
·
$41M
$0
$0
$0
Net Income TTM
$-293M
$1M
$-30M
$-32M
$-50M
$2M
$-72M
$-50M
$-32M
Market Cap
$174M
·
·
·
$274M
$800M
$2.22B
$2.10B
$1.88B
Enterprise Value
·
·
·
·
·
·
·
·
$1.75B
P/E
-0.1
11.7
-1.3
-0.3
-0.7
374.4
-30.7
·
·
P/S
·
·
·
·
·
19.4
·
·
·
P/B
-1.2
·
·
·
34.3
15.2
80.0
23.3
14.3
P / Tangible Book
·
·
·
·
·
35.4
·
·
·
P / Cash Flow
-12.9
·
·
·
-11.1
-23.6
-51.2
-50.1
606.4
P / FCF
·
·
·
·
·
·
·
·
616.8
EV / EBITDA
·
·
·
·
·
·
·
·
-42.5
EV / FCF
·
·
·
·
·
·
·
·
576.0
Earnings Yield
-862.4%
8.6%
-75.0%
-378.0%
-145.9%
0.27%
-3.2%
·
·
손익계산서11
NERV의 분기별 손익계산서 데이터
지표
추세
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
R&D Expense
$7M
$5M
$2M
$925.4K
$1M
$1M
$2M
$2M
$4M
$4M
$5M
$3M
$2M
$3M
$3M
$2M
SG&A Expense
$3M
$11M
$3M
$2M
$2M
$3M
$3M
$2M
$2M
$3M
$2M
$3M
$3M
$3M
$2M
$3M
Operating Expenses
$11M
$17M
$5M
$3M
$3M
$4M
$5M
$4M
$6M
$7M
$7M
$6M
$5M
$5M
$5M
$5M
Operating Income
$-11M
$-17M
$-5M
$-3M
$-3M
$-4M
$-5M
$-4M
$-6M
$-7M
$-7M
$-6M
$-5M
$-5M
$-5M
$-5M
Interest Income
$569.6K
$629.6K
$546.5K
$106.6K
$136.7K
$158.3K
$239.7K
$314.0K
$360.8K
$357.9K
$358.9K
$348.7K
$365.6K
$364.2K
$297.1K
$180.1K
Net Income
$17M
$-125M
$-284M
$-3M
$-3M
$-4M
$-4M
$23M
$-8M
$-9M
$-9M
$-8M
$-6M
$-7M
$-7M
$-7M
EPS (Basic)
$0.36
$-2.86
$-33.38
$-0.36
$-0.43
$-0.50
$-0.56
$2.97
$-1.09
$-1.13
$-1.15
$-1.03
$-1.12
$-1.31
$-1.26
$-1.29
EPS (Diluted)
$-0.14
$-2.86
$-33.38
$-0.36
$-0.43
$-0.50
$-0.56
$2.97
$-1.09
$-1.13
$-1.15
$-1.03
$-1.12
$-1.31
$-1.26
$-1.29
Shares (Basic)
46,599,044
43,900,426
-14,243,362
7,568,981
7,568,981
7,568,981
-15,137,962
7,568,981
7,568,981
7,568,981
-11,913,965
7,568,981
5,511,163
5,340,193
-10,680,391
5,340,193
Shares (Diluted)
79,104,585
43,900,426
-14,243,362
7,568,981
7,568,981
7,568,981
-15,133,180
7,568,981
7,568,981
7,568,981
-11,913,965
7,568,981
5,511,163
5,340,193
-10,680,391
5,340,193
EBITDA
$-11M
$-17M
·
$-3M
$-3M
$-4M
·
$-4M
$-6M
$-7M
·
$-6M
$-5M
$-5M
·
$-5M
대차대조표15
NERV의 분기별 대차대조표 데이터
지표
추세
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Cash & Equivalents
$25M
$33M
$82M
$12M
$15M
$17M
$21M
$27M
$31M
$35M
$41M
$47M
$52M
$36M
$36M
$40M
Short-term Investments
$51M
$45M
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Prepaid Expense
$4M
$941.9K
$697.7K
$633.5K
$199.6K
$534.8K
$806.9K
$1M
$428.0K
$702.5K
$989.9K
$1M
$329.2K
$596.0K
$848.1K
$1M
Current Assets
$80M
$79M
$83M
$13M
$16M
$18M
$22M
$28M
$31M
$36M
$42M
$48M
$52M
$37M
$40M
$45M
PP&E (Net)
·
·
$0
$1.4K
$2.7K
$4.1K
$5.4K
$6.8K
$8.2K
$9.5K
$10.9K
$12.2K
$13.6K
$15.0K
$16.3K
·
Goodwill
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
$15M
Total Assets
$95M
$94M
$98M
$28M
$30M
$33M
$37M
$43M
$46M
$51M
$57M
$63M
$67M
$52M
$55M
$60M
Accounts Payable
$1M
$2M
$639.7K
$944.5K
$896.8K
$639.9K
$2M
$553.2K
$828.3K
$1M
$2M
$1M
$298.3K
$961.0K
$969.7K
$532.9K
Current Liabilities
$4M
$4M
$2M
$3M
$3M
$2M
$3M
$4M
$4M
$3M
$3M
$3M
$2M
$3M
$1M
$2M
Total Liabilities
$297M
$343M
$234M
$63M
$63M
$62M
$63M
$64M
$91M
$87M
$85M
$83M
$80M
$78M
$75M
$74M
Common Stock
$4.7K
$4.4K
$4.3K
$699
$699
$699
$699
$699
$699
$699
$699
$699
$699
$534
$534
$534
Retained Earnings
$-797M
$-814M
$-689M
$-405M
$-402M
$-399M
$-395M
$-391M
$-414M
$-405M
$-397M
$-388M
$-380M
$-374M
$-367M
$-360M
Stockholders' Equity
$-213M
$-254M
$-141M
$-35M
$-32M
$-29M
$-26M
$-22M
$-44M
$-37M
$-28M
$-20M
$-13M
$-27M
$-20M
$-14M
Liabilities + Equity
$95M
$94M
$98M
$28M
$30M
$33M
$37M
$43M
$46M
$51M
$57M
$63M
$67M
$52M
$55M
$60M
Shares Outstanding
47,227,259
43,841,998
43,274,398
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
6,993,406
5,340,193
5,340,193
5,340,193
현금 흐름6
NERV의 분기별 현금 흐름 데이터
지표
추세
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
D&A
·
·
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
$1.4K
·
·
Stock-based Comp
$2M
$9M
$459.0K
$272.9K
$298.2K
$297.2K
$249.7K
$307.7K
$329.3K
$438.8K
$611.1K
$371.9K
$608.9K
$376.5K
$947.7K
$1M
Operating Cash Flow
$-13M
$-5M
$-4M
$-3M
$-2M
$-4M
$-5M
$-4M
$-4M
$-6M
$-6M
$-5M
$-4M
$-115.4K
$-4M
$-10M
Investing Cash Flow
$-5M
$-45M
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$-16.3K
·
Financing Cash Flow
$10M
$1M
$74M
$-45.2K
$0
$0
·
·
$0
$0
$0
$-86.7K
$20M
$0
$0
$0
Net Change in Cash
$-8M
$-50M
$70M
$-3M
$-2M
$-4M
$-5M
$-4M
$-4M
$-6M
$-6M
$-5M
$16M
$-115.4K
$-4M
$-10M
수익성2
NERV의 분기별 수익성 데이터
지표
추세
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
ROA
27.8%
-197.8%
·
-7.7%
-8.5%
-9.0%
·
42.5%
-14.5%
-16.8%
·
-12.7%
-9.4%
-11.4%
·
-8.8%
ROE
-14.2%
88.6%
·
9.8%
8.5%
11.4%
·
-107.9%
28.9%
27.1%
·
45.6%
59.3%
51.0%
·
-99.8%
유동성 및 지급능력2
NERV의 분기별 유동성 및 지급능력 데이터
지표
추세
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Current Ratio
20.1
17.6
·
4.9
6.1
9.2
·
6.2
7.5
12.6
·
14.4
27.4
14.7
·
20.4
Quick Ratio
19.0
17.4
·
4.6
6.0
8.9
·
5.9
7.3
12.3
·
14.0
27.1
14.4
·
18.3
주당4
NERV의 분기별 주당 데이터
지표
추세
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Book Value / Share
$-4.52
$-5.79
·
$-4.94
$-4.59
$-4.17
·
$-3.10
$-6.36
$-5.23
·
$-2.87
$-1.79
$-4.98
·
$-2.67
Cash Flow / Share
·
$-0.12
·
·
·
$-0.54
·
·
·
$-0.81
·
·
·
$-0.02
·
·
Cash / Share
$0.52
$0.74
·
$1.76
$2.18
$2.47
·
$3.79
$4.42
$4.98
·
$6.71
$7.41
$6.74
·
$7.53
EPS (TTM)
$-3.79
$-4.15
·
$1.68
$0.95
$0.25
·
$-0.28
$-4.37
$-4.59
·
$-4.75
$-5.35
$-6.06
·
$-6.47
가치 평가 (TTM)6
NERV의 분기별 가치 평가 (TTM) 데이터
지표
추세
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Net Income TTM
$-114M
$-135M
·
$13M
$7M
$2M
·
$-2M
$-31M
$-30M
·
$-28M
$-29M
$-32M
·
$-35M
Market Cap
$262M
$264M
·
$15M
$12M
$12M
·
$19M
$22M
$18M
·
$48M
$64M
$9M
·
$49M
P/E
-1.5
-1.5
·
1.3
1.8
6.8
·
-9.5
-0.7
-0.6
·
-1.5
-1.7
-0.3
·
-1.4
P/B
-1.2
-1.0
·
-0.4
-0.4
-0.4
·
-0.9
-0.5
-0.5
·
-2.4
-5.1
-0.3
·
-3.5
P / Cash Flow
·
-48.7
·
·
·
-2.9
·
·
·
-3.0
·
·
·
-74.0
·
·
Earnings Yield
-68.3%
-68.9%
·
79.8%
55.2%
14.7%
·
-10.5%
-137.0%
-177.9%
·
-68.8%
-58.5%
-378.8%
·
-70.1%
재무제표
손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
매출
—
$0
$0
$0
—
순이익
$-293M
$1M
$-30M
$-32M
$-50M
희석 EPS
$-34.67
$0.19
$-4.61
$-6.01
$-9.35
대차대조표
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
유동비율
36.3
—
—
—
22.1
당좌 비율
35.9
—
—
—
21.6
나의 지표
나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F)
60개의 제출자 · $216.5M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
신규 포지션
청산 포지션
증가함
감소
순주식 변동
27
(+13 이전 분기 대비)
7
(+4 이전 분기 대비)
10
(+2 이전 분기 대비)
11
(+3 이전 분기 대비)
+1.7M
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
INDEX VENTURE ASSOCIATES III LIMITED, INDEX VENTURES III (JERSEY) L.P., INDEX VENTURES III (DELAWARE) L.P., INDEX VENTURES III PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., INDEX VENTURE ASSOCIATES IV LIMITED, INDEX VENTURES IV (JERSEY) L.P., INDEX VENTURES IV PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., INDEX VENTURE ASSOCIATES V LIMITED, INDEX VENTURES V (JERSEY) L.P., INDEX VENTURES V PARALLEL ENTREPRENEUR FUND (JERSEY) L.P., YUCCA (JERSEY) SLP
×5 제출 서류
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황
11 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.